Journal
NATURE BIOTECHNOLOGY
Volume 32, Issue 8, Pages 786-794Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt.2960
Keywords
-
Categories
Funding
- NCI NIH HHS [P30 CA008748, P30 CA072720, K08 CA160659] Funding Source: Medline
- NHLBI NIH HHS [R01 HL069929] Funding Source: Medline
Ask authors/readers for more resources
Regenerative therapies that use allogeneic cells are likely to encounter immunological barriers similar to those that occur with transplantation of solid organs and allogeneic hematopoietic stem cells (HSCs). Decades of experience in clinical transplantation hold valuable lessons for regenerative medicine, offering approaches for developing tolerance-induction treatments relevant to cell therapies. Outside the field of solid-organ and allogeneic HSC transplantation, new strategies are emerging for controlling the immune response, such as methods based on biomaterials or mimicry of antigen-specific peripheral tolerance. Novel biomaterials can alter the behavior of cells in tissue-engineered constructs and can blunt host immune responses to cells and biomaterial scaffolds. Approaches to suppress autoreactive immune cells may also be useful in regenerative medicine. The most innovative solutions will be developed through closer collaboration among stem cell biologists, transplantation immunologists and materials scientists.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available